Zobrazeno 1 - 10
of 579
pro vyhledávání: '"Allogeneic BMT"'
Autor:
Sandra Fernandes, Robert Brooks, Matthew Gumbleton, Mi-Young Park, Christopher M. Russo, Kyle T. Howard, John D. Chisholm, William G. Kerr
Publikováno v:
EBioMedicine, Vol 2, Iss 3, Pp 205-213 (2015)
Hematopoietic stem cell transplantation (HSCT) is a highly effective procedure enabling long-term survival for patients with hematologic malignancy or heritable defects. Although there has been a dramatic increase in the success rate of HSCT over the
Externí odkaz:
https://doaj.org/article/803f7a54adcc4a47933a44e24a5b299d
Publikováno v:
Annals of Pediatric Surgery, Vol 16, Iss 1, Pp 1-6 (2020)
Background Bone marrow transplantation (BMT) is a therapeutic procedure for the management of several hematological diseases and malignancies in pediatric population. Central venous catheters (CVCs) play a pivotal role during the process of BMT. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c490d187b34fd6e34c4b1822d1cdc560
https://doaj.org/article/ce32c841982444538f710f8b48493ba5
https://doaj.org/article/ce32c841982444538f710f8b48493ba5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yoo, Heejung, Lee, Kyoohyung, Lee, Jehwan, Eremenco, Sonya, Choi, Seungjoon, Kim, Hwan, Lee, Jungshin
Publikováno v:
Quality of Life Research, 2006 Apr 01. 15(3), 559-564.
Externí odkaz:
https://www.jstor.org/stable/27641119
Autor:
A. Ghavamzadeh, M. Iravani, M. Jahani, B. Bahar, A. Mousavi, S. Gholibeikian, M. Jafari F. Safavifar
Publikováno v:
Acta Medica Iranica, Vol 41, Iss 4, Pp 220-226 (2003)
In this center, from 1991 to 2002, 89 chronic myelogenous leukemic (CML) patients, age ranging between 8-48 years with a median age of 29, underwent hematopoietic stem cell transplantation. Eighty-eight patients were in the first chronic phase of dis
Externí odkaz:
https://doaj.org/article/3cfa77c634ee42cfb82c093994cda25b
Autor:
Jeanette Falck Winther, Mukta Arora, Mariel Parman, Emily Ness, Lindsey Hageman, Saro H. Armenian, Jessica Wu, Liton Francisco, Anna Sällfors Holmqvist, Michelle Kung, Smita Bhatia, Kevin Battles, Joseph Rosenthal, Yanjun Chen
Publikováno v:
Holmqvist, A S, Chen, Y, Wu, J, Battles, K, Francisco, L, Hageman, L, Kung, M, Ness, E, Parman, M, Winther, J F, Rosenthal, J, Arora, M, Armenian, S H & Bhatia, S 2019, ' Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia ', Biology of Blood and Marrow Transplantation, vol. 25, no. 4, pp. 749-755 . https://doi.org/10.1016/j.bbmt.2018.12.063
Children with bone marrow failure syndromes and severe aplastic anemia (SAA) are treated with allogeneic blood or marrow transplantation (BMT). However, there is a paucity of studies examining late mortality risk after allogeneic BMT performed in chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0f7f16343c6b85108ccd85ec102fdd
https://doi.org/10.1016/j.bbmt.2018.12.063
https://doi.org/10.1016/j.bbmt.2018.12.063
Autor:
Raymond J. Steptoe, Daniel J. Browne, Rachel D. Kuns, Andrea S. Henden, Kate H. Gartlan, J. Paulo Martins, Kate A. Markey, Motoko Koyama, Melody Cheong, Thomas Brocker, Renee J. Robb, Mark J. Smyth, Mariapia A. Degli-Esposti, Simone A. Minnie, Geoffrey R. Hill, Steven W. Lane, Gabrielle T. Belz
Publikováno v:
Clinical Cancer Research. 24:1604-1616
Purpose: Allogeneic bone marrow transplantation (BMT) provides curative therapy for leukemia via immunologic graft-versus-leukemia (GVL) effects. In practice, this must be balanced against life threatening pathology induced by graft-versus-host disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4406524c4676abe247997ae523cf949b
https://doi.org/10.1158/1078-0432.ccr-17-2148
https://doi.org/10.1158/1078-0432.ccr-17-2148
Autor:
Catherine M. Bollard, David A. Jacobsohn, Kenneth R. Cooke, Nan Zhang, Anushree Datar, Hema Dave, Jeffrey S. Dome, Maja Stanojevic, Kirsten M. Williams, Maria Fernanda Fortiz, Michael D. Keller, Hua Liang, Conrad Russell Y. Cruz, Jay Tanna, Fahmida Hoq, Melanie Grant, Hannah Kinoshita, Patrick J. Hanley, Richard J. Jones, Abeer Shibli, John Barrett, Haili Lang
Publikováno v:
Blood. 138:2828-2828
Background: Patients with hematologic malignancies relapsing after allogeneic blood or marrow transplantation (BMT) have limited response to conventional salvage therapies with an expected 1-year overall survival (OS) of Methods: Lymphocytes obtained
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ce6fee4ad6235771006b5e378e32f34
https://doi.org/10.1182/blood-2021-153207
https://doi.org/10.1182/blood-2021-153207
Autor:
Jingxia Li, Shuhua Wang, Alina Ulezko Antonova, Khajan Ghandhi, Cynthia R. Giver, Jian-Ming Li, Edmund K. Waller, Jingru Zhu, Tamas Nagy, Pankoj Kumar Das, Sruthi Ravindranathan, John D. Roback, Yitong Wang, Yiwen Li
Publikováno v:
Blood. 138:1687-1687
Introduction: Vasoactive intestinal peptide (VIP) is an anti-inflammatory neuropeptide known to induce differentiation of regulatory dendritic cells and regulatory T cells. Using allogeneic hematopoietic stem cell transplantation (allo-HSCT) models,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6819aacb95effc1acbcb364482a6e79f
https://doi.org/10.1182/blood-2021-152945
https://doi.org/10.1182/blood-2021-152945
Autor:
Marcelo C. Pasquini, Abbas Rizvi, Qianqian Zhu, Leah Preus, Junke Wang, Lara E. Sucheston-Campbell, Alyssa I. Clay-Gilmour, Philip L. McCarthy, Christopher A. Haiman, Stephen R. Spellman, Theresa Hahn, David Van Den Berg, Guy Brock, Xin Sheng, Loreall Pooler, Yiwen Wang, Amy Webb, Song Liu, Daniel O. Stram, Ezgi Karaesmen, Li Yan, Kenan Onel
Publikováno v:
EClinicalMedicine
Background Identification of non-human leukocyte antigen (HLA) genetic risk factors could improve survival after allogeneic blood or marrow transplant (BMT) through matching at additional loci or individualizing risk prediction. We hypothesized that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41e4237a7907fda5c75c4caa7956c3c3
https://doi.org/10.1016/j.eclinm.2021.101093
https://doi.org/10.1016/j.eclinm.2021.101093